Cost-Effectiveness Analysis of Selexipag Versus Inhaled Iloprost In The Treatment of Pulmonary Arterial Hypertension (PAH) In Sweden
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.1214
https://www.valueinhealthjournal.com/article/S1098-3015(16)32580-3/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1139
First Page :
A556
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32580-3&doi=10.1016/j.jval.2016.09.1214